GT Biopharma, Inc. Common Stock — Institutional Ownership
Which tracked institutions hold GTBP, and how they changed the position last quarter. Latest holdings as of Mar 31, 2026. Source: SEC 13-F filings.
7
Funds holding
$31012
Total value held
Buying
5 added/new · 2 reduced
| # | Institution | Value | Shares | Δ Shares | Change (QoQ) |
|---|---|---|---|---|---|
| 1 | Wells Fargo & Company/Mn | $12592 | 16037 | +6025 | +60.18% |
| 2 | Morgan Stanley | $6774 | 16599 | -2000 | -10.75% |
| 3 | Stonex Group Inc. | $6022 | 14756 | +14756 | NEW BUY |
| 4 | Blackrock, Inc. | $3431 | 8408 | -1 | -0.01% |
| 5 | Citigroup Inc | $2184 | 2781 | +2781 | NEW BUY |
| 6 | Amalgamated Financial Corp. | $9 | 2959 | +2959 | NEW BUY |
| 7 | Royal Bank Of Canada | $0 | 126 | +126 | NEW BUY |
Aggregated across tracked institutional filers. Reported quarterly on SEC Form 13-F and may lag. For research only — not investment advice.